A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01685489
Recruitment Status : Withdrawn (funding sequestered)
First Posted : September 14, 2012
Last Update Posted : October 27, 2015
University of Washington
Fred Hutchinson Cancer Research Center
Information provided by (Responsible Party):
Bastyr University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given